These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7001917)

  • 1. Immunological and biological studies on cholecystokinin in rat brain.
    Lamers CB; Morley JE; Poitras P; Sharp B; Carlson HE; Hershman JM; Walsh JH
    Am J Physiol; 1980 Sep; 239(3):E232-5. PubMed ID: 7001917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholecystokinin octapeptide on the pancreatic exocrine secretion in the pig.
    Cuber JC; Corring T; Levenez F; Bernard C; Chayvialle JA
    Can J Physiol Pharmacol; 1989 Nov; 67(11):1391-7. PubMed ID: 2627679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The release of rat intestinal cholecystokinin after oral trypsin inhibitor measured by bio-assay.
    Brand SJ; Morgan RG
    J Physiol; 1981; 319():325-43. PubMed ID: 7320918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro release of cholecystokinin octapeptide-like immunoreactivity from rat brain synaptosomes.
    Klaff LJ; Hudson A; Sheppard M; Tyler M
    S Afr Med J; 1981 Jan; 59(5):158-60. PubMed ID: 7455849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement and characterisation of human cholecystokinin-like immunoreactivity (CCK-LI) in tissues by radioimmunoassay.
    Bacarese-Hamilton AJ; Adrian TE; Bloom SR
    Clin Chim Acta; 1984 Dec; 144(2-3):213-24. PubMed ID: 6529856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin-like immunoreactivity in frog retina: localization, characterization, and biosynthesis.
    Yamada T; Brecha N; Rosenquist G; Basinger S
    Peptides; 1981; 2 Suppl 2():93-7. PubMed ID: 6283502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat immunoreactive cholecystokinin (CCK): characterization using two chromatographic techniques.
    Bacarese-Hamilton AJ; Adrian TE; Chohan P; Bloom SR
    Regul Pept; 1985 Jun; 11(2):149-58. PubMed ID: 4035007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of immunoreactive CCK and VIP in pig brain and gut.
    Ichihara K; Eng J; Pond WG; Yen JT; Straus E; Yalow RS
    Peptides; 1984; 5(3):623-6. PubMed ID: 6089147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and heterogeneity of immunoreactive cholecystokinin (CCK) in the mucosa of the porcine gastrointestinal tract.
    Bacarese-Hamilton AJ; Adrian TE; Bloom SR
    Regul Pept; 1984 Nov; 9(4):289-98. PubMed ID: 6522644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of biologically active and inactive cholecystokinin-octapeptides from human brain.
    Reeve JR; Eysselein VE; Walsh JH; Sankaran H; Deveney CW; Tourtellotte WW; Miller C; Shively JE
    Peptides; 1984; 5(5):959-66. PubMed ID: 6209688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay.
    Beinfeld MC; Meyer DK; Eskay RL; Jensen RT; Brownstein MJ
    Brain Res; 1981 May; 212(1):51-7. PubMed ID: 7225864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational processing of cholecystokinin in pig brain and gut.
    Eng J; Shiina Y; Straus E; Yalow RS
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6060-4. PubMed ID: 6964399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in the development of cholecystokinin-like activity in rat brain.
    Varró A; Bu'lock AJ; Williams RG; Dockray GJ
    Brain Res; 1983 Sep; 285(3):347-52. PubMed ID: 6313134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus.
    Schick RR; Reilly WM; Roddy DR; Yaksh TL; Go VL
    Brain Res; 1987 Aug; 418(1):20-6. PubMed ID: 3664270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthritis-induced increase in cholecystokinin release in the rat anterior cingulate cortex is reversed by diclofenac.
    Heilborn U; Rost BR; Arborelius L; Brodin E
    Brain Res; 2007 Mar; 1136(1):51-8. PubMed ID: 17229410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma.
    Eysselein VE; Böttcher W; Kauffman GL; Walsh JH
    Regul Pept; 1984 Oct; 9(3):173-85. PubMed ID: 6098939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of procholecystokinin processing in rat hypothalamus.
    Mogensen NW; Hilsted L; Bardram L; Rehfeld JF
    Dev Neurosci; 1991; 13(2):104-9. PubMed ID: 2070745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and organ catabolism of cholecystokinin octapeptide in pigs.
    Cuber JC; Bernard C; Gibard T; Chayvialle JA
    Regul Pept; 1989 Dec; 26(3):203-13. PubMed ID: 2623187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal peptides in the brain.
    Straus E; Yalow RS
    Fed Proc; 1979 Aug; 38(9):2320-4. PubMed ID: 110622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of molecular forms of CCK-peptides in rat brain and gut.
    Ichihara K; Eng J; Yalow RS
    Life Sci; 1984 Jan; 34(1):93-8. PubMed ID: 6694513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.